微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 3.63% | -0.27% | 41.8% | 77/159 | 1.21% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 2.56% | 16.89% | 190.91% | 70/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.88% | -38.03% | -76.53% | 87/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 3.75% | 27.55% | 3.02% | 68/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 3.64% | -15.15% | 66.21% | 76/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.19% | 39.49% | 54.23% | 77/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.42% | 40.59% | -51.7% | 75/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 2.94% | -24.42% | -31.47% | 80/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 4.29% | 12.89% | 173.25% | 77/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.57% | -36.69% | 55.45% | 91/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.01% | -15.83% | -74.04% | 93/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 3.89% | -56.92% | 2.37% | 83/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 3.8% | -41.18% | 53.23% | 74/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.48% | -43.12% | 106.67% | 76/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.2% | 2% | -86.71% | 84/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 9.03% | -3.11% | 39.78% | 47/159 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 6.46% | 2% | 48.17% | 62/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 4.36% | 20.44% | -53.22% | 64/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | 9.32% | -20.07% | 157.46% | 59/159 | 3.58% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-06-30 | 3.62% | -54.41% | -68.95% | 68/159 | 4.19% | 哈三联 | 27.17% | 行业排名> |
| 2019-12-31 | 11.66% | 24.17% | 24.17% | 45/159 | 2.53% | 汇宇制药 | 55.94% | 行业排名> |
| 2018-12-31 | 9.39% | -25.77% | -25.77% | 54/159 | 6.99% | 河化股份 | 45.32% | 行业排名> |
| 2017-12-31 | 12.65% | 2% | 59.32% | 35/159 | 9.61% | 汇宇制药 | 31.9% | 行业排名> |
| 2015-06-30 | 7.94% | 2% | 2% | 20/159 | 4.87% | 誉衡药业 | 35.56% | 行业排名> |